Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm
Interventions: DRUG: Sagopilone (ZK 219477)|DRUG: Sagopilone (ZK 219477)
Sponsor: Bayer